|
2024
|
Invention
|
Combination of latrepirdine and a pharmacokinetic stabilizer. The present disclosure relates to a... |
|
|
Invention
|
Methods and compositions for treating agitation.
The present disclosure relates to the treatment... |
|
|
P/S
|
Pharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for... |
|
|
Invention
|
Dexmedetomidine treatment regimens. Disclosed herein are methods of administering dexmedetomidine... |
|
|
Invention
|
Prevention or treatment of sleep disorders using dexmedetomidine formulation.
There is provided ... |
|
|
Invention
|
Non-sedating dexmedetomidine treatment regimens. Disclosed herein are methods of administering re... |
|
|
Invention
|
Use of sublingual dexmedetomidine for the treatment of agitation.
The present invention disclose... |
|
2023
|
Invention
|
Methods for treating agitation in community settings. The present disclosure relates to methods o... |
|
|
Invention
|
Methods and compositions for treating acute stress disorder. The present disclosure relates to th... |
|
|
Invention
|
Film formulations containing dexmedetomidine and methods of producing them.
Disclosed herein is ... |
|
|
Invention
|
Non-sedating dexmedetomidine treatment regimens.
Disclosed herein are methods of administering r... |
|
2022
|
Invention
|
Use of sublingual dexmedetomidine for the treatment of agitation. The present invention discloses... |
|
|
Invention
|
Systems and methods for detection and prevention of emergence of agitation.
Disclosed in the pre... |
|
|
Invention
|
Methods for treating depressive states. The present disclosure relates to method of treating or p... |
|
|
Invention
|
Systems and methods of using machine learning to detect and predict emergence of agitation based ... |
|
|
Invention
|
Methods and compositions for treating agitation. The present disclosure relates to the treatment ... |
|
|
Invention
|
Dexmedetomidine treatment regimens.
Disclosed herein are methods of administering dexmedetomidin... |
|
2021
|
Invention
|
Film formulations containing dexmedetomidine and methods of producing them. Disclosed herein is a... |
|
|
Invention
|
Treatment of bipolar disorders and psychosis using dexmedetomidine hydrochloride.
Disclosed here... |
|
|
Invention
|
Treatment of bipolar disorders and psychosis using dexmedetomidine hydrochloride. Disclosed herei... |
|
|
P/S
|
Pharmaceuticals for the treatment of agitation;
pharmaceuticals for the treatment of agitation a... |
|
|
Invention
|
Systems and methods for detection and prevention of emergence of agitation. Disclosed in the pres... |
|
|
Invention
|
Treatment regimen for cancer using immunomodulation. The present disclosure provides a regimen fo... |
|
2020
|
P/S
|
Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation as... |
|
|
P/S
|
Pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for the treat... |
|
|
P/S
|
Pharmaceutical preparations in the field of immuno-oncology; pharmaceutical preparations for the ... |
|
|
P/S
|
Pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, namel... |
|
|
P/S
|
Injectable pharmaceuticals for the treatment of agitation; injectable pharmaceuticals for the tre... |
|
2019
|
Invention
|
Novel approach for treatment of cancer using immunomodulation. The present disclosure provides a ... |
|
|
Invention
|
Combination therapies for treating disease using an innate immunity modifier and an ox40 agonist.... |
|
|
Invention
|
Methods for treating agitation using dexmedetomidine hydrochloride.
The present disclosure relat... |
|
|
Invention
|
Methods for treating agitation using dexmedetomidine hydrochloride. The present disclosure relate... |
